<?xml version="1.0" encoding="UTF-8"?>
<notes>
 <p content-type="self-citation">
  <mixed-citation publication-type="journal" id="jia225551-cit-1001">
   <string-name>
    <surname>Holloway</surname>, 
    <given-names>I. W.</given-names>
   </string-name>, 
   <string-name>
    <surname>Spaulding</surname>, 
    <given-names>A. C.</given-names>
   </string-name>, 
   <string-name>
    <surname>Miyashita Ochoa</surname>, 
    <given-names>A.</given-names>
   </string-name>, 
   <string-name>
    <surname>Randall</surname>, 
    <given-names>L. A.</given-names>
   </string-name>, 
   <string-name>
    <surname>King</surname>, 
    <given-names>A. R.</given-names>
   </string-name>; 
   <collab collab-type="authors">The HBOU Study Team</collab> and 
   <string-name>
    <surname>Frew</surname>, 
    <given-names>P. M.</given-names>
   </string-name>
   <article-title>COVID‚Äê19 vulnerability among people who use drugs: recommendations for global public health programmes and policies</article-title>. 
   <source xml:lang="en">J Int AIDS Soc</source>. 
   <year>2020</year>; 
   <volume>23</volume>(7):
   <elocation-id>e25551</elocation-id>
  </mixed-citation>
 </p>
</notes>
